Edesa Biotech (EDSA) Cash from Operations (2013 - 2025)
Edesa Biotech (EDSA) posted Cash from Operations of 2100000.0 for Q4 2025, down 23.62% sequentially from 1698732.0 in Q3 2025, and down 38.41% YoY from 3409787.93 in Q4 2024.
Edesa Biotech (EDSA) Cash from Operations (2013 - 2025) Analysis & Trends
Edesa Biotech has reported Cash from Operations for 13 years, with the latest figure at 2100000.0 in Q4 2025.
- Quarterly Cash from Operations fell 38.41% year-over-year to 2100000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 7882797.0 (down 57.32% YoY) and the FY2025 annual result came in at 7300000.0, down 48.98% from the prior year.
- Cash from Operations declined to 2100000.0 in Q4 2025 per EDSA's latest filing, from 1698732.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 355321.0 in Q3 2021 and troughed at 7179528.0 in Q1 2021.
- A 5-year average of 2191685.25 and a median of 1699749.5 in 2025 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 94.2% in 2022, down 1483.98% in 2022.
- Over 5 years, Cash from Operations stood at 3207614.0 in 2021, then jumped by 44.16% to 1791095.0 in 2022, then advanced by 21.47% to 1406528.0 in 2023, then retreated by 7.87% to 1517203.0 in 2024, then slumped by 38.41% to 2100000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 2100000.0, 1698732.0, and 1700767.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Edesa Biotech | 40.44 Mn | 40.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.10 Mn |
| Dec 31, 2025 | -2.10 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Jun 30, 2025 | -1.70 Mn |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | -2.38 Mn |
| Mar 31, 2025 | -2.38 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -976,834.00 |
| Sep 30, 2024 | -976,834.00 |
| Jun 30, 2024 | -856,479.00 |
| Jun 30, 2024 | -856,479.00 |
| Mar 31, 2024 | -1.66 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | -1.41 Mn |
| Dec 31, 2023 | -1.41 Mn |
| Sep 30, 2023 | -1.43 Mn |
| Sep 30, 2023 | -1.43 Mn |